Scipher Medicine is evolving its strategy to expand beyond rheumatoid arthritis diagnostics toward broader personalized medicine using clinicogenomic datasets. Under new leadership, Scipher now leverages the world's largest non-oncology clinical transcriptomic dataset, aiming to replicate successes seen in oncology precision medicine. The company has forged multiple data-sharing partnerships with pharma and informatics firms to enhance biomarker discovery and drug development across immunology and other non-cancer diseases. Scipher's CEO Reg Seeto emphasizes immunology as an understudied space primed for breakthroughs through integrated molecular data platforms, positioning the company at the forefront of data-driven precision therapeutics.